Research Gynecologic Cancer Magazine Ovarian Cancer
Ovarian cancer is a growing area of research at the University of Colorado Cancer Center. A newly formed Ovarian Cancer Innovations Group, envisioned by Saketh Guntupalli, MD, and led by Kian Behbakht, MD, MBA, is taking a multipronged approach to studying the disease.
Research Community Awareness Gynecologic Cancer Vaccinations Cervical Cancer
Even as exciting developments are happening in cervical cancer research, an estimated 14,100 new cases of invasive cervical cancer will be diagnosed in the United States this year.
Gynecologic Cancer Vaccinations Cervical Cancer
January is Cervical Cancer Awareness Month, and CU Cancer Center member Lindsay Brubaker, MD, wants everyone to be aware of the relationship between cervical cancer and the human papillomavirus (HPV), a sexually-transmitted disease that causes the vast majority of cervical cancers. The current HPV vaccine protects against seven predominant strains of the virus that cause cancer, as well as the two that cause genital warts.
Press Coverage Gynecologic Cancer
Peyton taught the world that ovarian cancer doesn’t just strike mothers and grandmothers. “She’s brought so much awareness to the disease through her advocacy,” said CU Cancer Center member Saketh Guntupalli, MD.
Research Gynecologic Cancer Ovarian Cancer
After nearly four years of work, a group of researchers and clinicians from the University of Colorado (CU) published a paper this week in the Clinical Cancer Research that shares findings from research looking at how the composition of ovarian cancer tumors changes during chemotherapy and contributes to therapeutic response.
Research Gynecologic Cancer Cervical Cancer
Last month the American Cancer Society (ACS) released updated guidelines for cervical cancer screening. The most notable change in guidelines is the changes in the age to begin screening. Per the new guidelines, it is recommended that cervical cancer screening begin at age 25. Previously, the starting age for screening was 21.
Philanthropy Gynecologic Cancer Cancer Ovarian Cancer
In July 2019, Emily McClintock Addlesperger was on vacation in Maine with her husband, Jason, when she felt sick and was airlifted to Portland with internal bleeding. A tumor on her ovary had burst. It was Monday. On Saturday, she passed away. Emily was 44 years old.
Gynecologic Cancer Clinical Research
Brad Corr’s inspiration to pursue a medical career came on the ski slopes of Big Sky, Montana.
This July, University of Colorado Cancer Center investigator, Saketh Guntupalli, MD, assumes the role of Division Chief of the CU School of Medicine Department of Obstetrics and Gynecology Division of Gynecologic Oncology, with a mission to increase the excellence of clinical care, train the next generation of physician-scientists, and move the needle on gynecologic cancer research. Guntupalli takes over a program that already boasts 15-20 percent improved survival rates over national averages for some cancers including uterine cancer.
Sexual health can be an uncomfortable subject after completing cancer treatment, but is an important quality of life issue. A University of Colorado Cancer Center study presented at the 2019 American Society of Clinical Oncology (ASCO) conference in Chicago highlights the unmet need of interventions to improve and maintain optimal sexual health.
In women at high risk for ovarian cancer, the common prevention strategy is to remove fallopian tubes and ovaries as soon as the woman is done having a family – the sooner the better. But this initiates menopause and along with it higher risk of cardiovascular disease, osteoporosis, sexual side-effects, and perhaps even Alzheimer’s disease. A recent University of Colorado Cancer Center review in the International Journal of Gynecologic Cancer suggests a way young, high-risk women can reduce risk while leaving menopause for later: the technique known as salpingectomy removes the fallopian tubes while leaving ovaries intact.
UCHealth
December 01, 2023
Betty Moren was told she had six to nine months to live.
More than six years and countless treatments later, she’s still here.
KDVR
November 27, 2023
The lab of Angelo D’Alessandro, PhD, a professor at the CU School of Medicine, had already been working with Cambridge to understand the metabolic support of neurodegeneration in multiple sclerosis, with a special focus on the role of metabolic signals driving inflammatory events that make immune cells in the brain turn against neurons.
The Denver Post
November 26, 2023
Devon Brown knew not to ignore it when she found a lump in her breast that just didn’t seem quite right. “It felt very round and hard, so that was pretty abnormal,” she said.
Colorado Public Radio
November 16, 2023
CU Cancer Center member Jan Lowery, PhD, MPH, Assistant Director, Dissemination and Implementation, Office of Community Outreach and Engagement, was briefly interviewed on Colorado Public Radio about radon and lung cancer.
Greg Glasgow
